170 related articles for article (PubMed ID: 34214968)
1. Pediatric Hodgkin Lymphoma, Version 3.2021.
Flerlage JE; Hiniker SM; Armenian S; Benya EC; Bobbey AJ; Chang V; Cooper S; Coulter DW; Cuglievan B; Hoppe BS; Isenalumhe L; Kelly K; Kersun L; Lamble AJ; Larrier NA; Magee J; Oduro K; Pacheco M; Price AP; Roberts KB; Smith CM; Sohani AR; Trovillion EM; Walling E; Xavier AC; Burns JL; Campbell M
J Natl Compr Canc Netw; 2021 Jun; 19(6):733-754. PubMed ID: 34214968
[TBL] [Abstract][Full Text] [Related]
2. NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.
Hoppe RT; Advani RH; Ai WZ; Ambinder RF; Aoun P; Armand P; Bello CM; Benitez CM; Bierman PJ; Chen R; Dabaja B; Dean R; Forero A; Gordon LI; Hernandez-Ilizaliturri FJ; Hochberg EP; Huang J; Johnston PB; Kaminski MS; Kenkre VP; Khan N; Maddocks K; Maloney DG; Metzger M; Moore JO; Morgan D; Moskowitz CH; Mulroney C; Rabinovitch R; Seropian S; Tao R; Winter JN; Yahalom J; Burns JL; Ogba N
J Natl Compr Canc Netw; 2018 Mar; 16(3):245-254. PubMed ID: 29523663
[TBL] [Abstract][Full Text] [Related]
3. Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.
Hoppe RT; Advani RH; Ai WZ; Ambinder RF; Aoun P; Bello CM; Benitez CM; Bernat K; Bierman PJ; Blum KA; Chen R; Dabaja B; Forero A; Gordon LI; Hernandez-Ilizaliturri FJ; Hochberg EP; Huang J; Johnston PB; Kaminski MS; Kenkre VP; Khan N; Maloney DG; Mauch PM; Metzger M; Moore JO; Morgan D; Moskowitz CH; Mulroney C; Poppe M; Rabinovitch R; Seropian S; Smith M; Winter JN; Yahalom J; Burns J; Ogba N; Sundar H
J Natl Compr Canc Netw; 2017 May; 15(5):608-638. PubMed ID: 28476741
[TBL] [Abstract][Full Text] [Related]
4. Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Hoppe RT; Advani RH; Ai WZ; Ambinder RF; Armand P; Bello CM; Benitez CM; Bierman PJ; Boughan KM; Dabaja B; Gordon LI; Hernandez-Ilizaliturri FJ; Herrera AF; Hochberg EP; Huang J; Johnston PB; Kaminski MS; Kenkre VP; Khan N; Lynch RC; Maddocks K; McConathy J; McKinney M; Metzger M; Morgan D; Mulroney C; Rabinovitch R; Rosenspire KC; Seropian S; Tao R; Winter JN; Yahalom J; Burns JL; Ogba N
J Natl Compr Canc Netw; 2020 Jun; 18(6):755-781. PubMed ID: 32502987
[TBL] [Abstract][Full Text] [Related]
5. Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines.
Hoppe RT; Advani RH; Ai WZ; Ambinder RF; Aoun P; Bello CM; Bierman PJ; Blum KA; Chen R; Dabaja B; Duron Y; Forero A; Gordon LI; Hernandez-Ilizaliturri FJ; Hochberg EP; Maloney DG; Mansur D; Mauch PM; Metzger M; Moore JO; Morgan D; Moskowitz CH; Poppe M; Pro B; Winter JN; Yahalom J; Sundar H;
J Natl Compr Canc Netw; 2012 May; 10(5):589-97. PubMed ID: 22570290
[TBL] [Abstract][Full Text] [Related]
6. NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022.
Hoppe RT; Advani RH; Ai WZ; Ambinder RF; Armand P; Bello CM; Benitez CM; Chen W; Dabaja B; Daly ME; Gordon LI; Hansen N; Herrera AF; Hochberg EP; Johnston PB; Kaminski MS; Kelsey CR; Kenkre VP; Khan N; Lynch RC; Maddocks K; McConathy J; Metzger M; Morgan D; Mulroney C; Pullarkat ST; Rabinovitch R; Rosenspire KC; Seropian S; Tao R; Torka P; Winter JN; Yahalom J; Yang JC; Burns JL; Campbell M; Sundar H
J Natl Compr Canc Netw; 2022 Apr; 20(4):322-334. PubMed ID: 35390768
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of Hodgkin lymphoma in children, adolescents, and young adults.
Belsky JA; Hochberg J; Giulino-Roth L
Best Pract Res Clin Haematol; 2023 Mar; 36(1):101445. PubMed ID: 36907636
[TBL] [Abstract][Full Text] [Related]
8. Pediatric Aggressive Mature B-Cell Lymphomas, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Davies K; Barth M; Armenian S; Audino AN; Barnette P; Cuglievan B; Ding H; Ford JB; Galardy PJ; Gardner R; Hanna R; Hayashi R; Kovach AE; Machnitz AJ; Maloney KW; Marks L; Page K; Reilly AF; Weinstein JL; Xavier AC; McMillian NR; Freedman-Cass DA
J Natl Compr Canc Netw; 2020 Aug; 18(8):1105-1123. PubMed ID: 32755986
[TBL] [Abstract][Full Text] [Related]
9. Integration of Pediatric Hodgkin Lymphoma Treatment and Late Effects Guidelines: Seeing the Forest Beyond the Trees.
Ehrhardt MJ; Flerlage JE; Armenian SH; Castellino SM; Hodgson DC; Hudson MM
J Natl Compr Canc Netw; 2021 Jun; 19(6):755-764. PubMed ID: 34214967
[TBL] [Abstract][Full Text] [Related]
10. A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation.
Taçyıldız N; Tanyıldız HG; Ünal E; Dinçaslan H; Asarcıklı F; Aksoy BA; Vatansever G; Yavuz G
Turk J Pediatr; 2019; 61(5):671-676. PubMed ID: 32104998
[TBL] [Abstract][Full Text] [Related]
11. Pediatric Hodgkin Lymphoma.
Mauz-Körholz C; Metzger ML; Kelly KM; Schwartz CL; Castellanos ME; Dieckmann K; Kluge R; Körholz D
J Clin Oncol; 2015 Sep; 33(27):2975-85. PubMed ID: 26304892
[TBL] [Abstract][Full Text] [Related]
12. Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Brown P; Inaba H; Annesley C; Beck J; Colace S; Dallas M; DeSantes K; Kelly K; Kitko C; Lacayo N; Larrier N; Maese L; Mahadeo K; Nanda R; Nardi V; Rodriguez V; Rossoff J; Schuettpelz L; Silverman L; Sun J; Sun W; Teachey D; Wong V; Yanik G; Johnson-Chilla A; Ogba N
J Natl Compr Canc Netw; 2020 Jan; 18(1):81-112. PubMed ID: 31910389
[TBL] [Abstract][Full Text] [Related]
13. Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents.
Giulino-Roth L; Keller FG; Hodgson DC; Kelly KM
Br J Haematol; 2015 Jun; 169(5):647-60. PubMed ID: 25824371
[TBL] [Abstract][Full Text] [Related]
14. SEOM clinical guidelines for the treatment of Hodgkin's lymphoma.
Rueda Domínguez A; Alfaro Lizaso J; de la Cruz Merino L; Gumá I Padró J; Quero Blanco C; Gómez Codina J; Llanos Muñoz M; Martinez Banaclocha N; Rodriguez Abreu D; Provencio Pulla M
Clin Transl Oncol; 2015 Dec; 17(12):1005-13. PubMed ID: 26497354
[TBL] [Abstract][Full Text] [Related]
15. Imaging recommendations in pediatric lymphoma: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.
Mhlanga J; Alazraki A; Cho SY; Lai H; Nadel H; Pandit-Taskar N; Qi J; Rajderkar D; Voss S; Watal P; McCarten K
Pediatr Blood Cancer; 2023 Jun; 70 Suppl 4(Suppl 4):e29968. PubMed ID: 36114654
[TBL] [Abstract][Full Text] [Related]
16. High dose chemotherapy and autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: Emerging questions, newer agents, and changing paradigm.
Akhtar S
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):272-276. PubMed ID: 28641095
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin lymphoma.
Gobbi PG; Ferreri AJ; Ponzoni M; Levis A
Crit Rev Oncol Hematol; 2013 Feb; 85(2):216-37. PubMed ID: 22867814
[TBL] [Abstract][Full Text] [Related]
18. Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: a children's oncology group report.
Trippett TM; Schwartz CL; Guillerman RP; Gamis AS; Gardner S; Hogan S; London WB; Chen L; de Alarcon P
Pediatr Blood Cancer; 2015 Jan; 62(1):60-4. PubMed ID: 25308760
[TBL] [Abstract][Full Text] [Related]
19. The pediatric approach to Hodgkin lymphoma.
Heneghan MB; Belsky JA; Milgrom SA; Forlenza CJ
Semin Hematol; 2024 May; ():. PubMed ID: 38851951
[TBL] [Abstract][Full Text] [Related]
20. Optimal therapy of advanced Hodgkin lymphoma.
Advani R
Hematology Am Soc Hematol Educ Program; 2011; 2011():310-6. PubMed ID: 22160051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
